pharma

Esperion Names Sheldon Koenig President, CEO

ANN ARBOR—Esperion Therapeutics Inc. announced the appointment of Sheldon Koenig as president, CEO, and board member, effective immediately. He succeeds Tim Mayleben, whom company officials said “decided to step down” after a decade as the company’s CEO. Mayleben will continue to serve as a senior advisor “to help ensure a smooth transition,” company officials said

By |2021-05-17T20:20:48-04:00May 17th, 2021|Life Sciences|

Genomenon Completes $5.3 Million Financing Round

ANN-ARBOR—Genomenon, the genetics informatics company, has completed a $5.3 million financing round, company officials announced.  The financing will enable the company to expand its commercial operations, which serve genetic testing labs, hospitals, pharmaceutical and biopharma companies. New investors in this round of financing included BroadOak Capital Partners LLC of Bethesda, Md., Green Park & Golf

By |2021-03-26T15:10:29-04:00March 26th, 2021|Life Sciences, Life Sciences/Biotech|

What Are The New Social Media Rules For Those Vaccinated?

ANN ARBOR - Epidemiologist Fred Brown explains what anyone receiving the COVID vaccines should do before they plan large gatherings with family and friends this summer....probably the earliest safe mixer can occur. Trained as a medicinal biochemist, Brown has been on the discovery, development and/or launch teams of 27 major pharmaceutical, 13 diagnostic and 6

By |2021-03-19T14:38:54-04:00March 19th, 2021|Coronavirus, mitechtv, Science|

Survey: Half Of Americans Say They Will Receive COVID-19 Vaccine When Available

NEW YORK—A groundbreaking “Back-to-Normal Barometer” survey for the first time finds that half of Americans say that they will receive a COVID-19 vaccine once it becomes available for them to receive it.  Driving this lack of enthusiasm, 60% of people surveyed don’t believe a vaccine is safe for them to take, while 40% of people

By |2021-02-19T16:10:26-05:00February 19th, 2021|Coronavirus, Science|

COVID Vaccine Update With Epidemiologist Fred Brown

ANN ARBOR - Epidemiologist Fred Brown discusses both the failures and successes in developing COVID-19 vaccines not only in the United States, but around the world. He also speculates on whether President Biden can achieve his goal of getting 100 million vaccinations done within the first 100 days of his administration. Trained as a medicinal

By |2021-01-30T15:02:56-05:00January 30th, 2021|Coronavirus, mitechtv, Science|

MMS Contract Pharma Researcher Joins Healthcare Alliance

CANTON TWP.–MMS Holdings, a contract research organization for the pharmaceutical industry, has joined the Decentralized Trials and Research Alliance, an organization launched in December to unite healthcare companies, regulators, patient groups and research organizations to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research. “As a

By |2021-01-30T11:14:45-05:00January 30th, 2021|Life Sciences, Life Sciences/Biotech|

HealthBar Offers Drive-Thru COVID-19 Testing In Grand Rapids

GRAND RAPIDS — A startup in West Michigan looking to cut the middleman from healthcare is offering drive-thru COVID-19 testing in Grand Rapids. HealthBar (formerly HealthBaar) was founded by longtime nurse Nathan Baar, who saw a need for accessibility and price transparency in healthcare. The service is focused on providing businesses with basic healthcare needs

By |2021-01-04T18:49:36-05:00January 4th, 2021|Coronavirus, Science|

Are COVID-19 Vaccines Safe?

ANN ARBOR - The Pfizer and Moderna COVID-19 vaccines are now available and millions of people have been vaccinated. But the lingering question remains are they safe, since they were developed in record time. Epidemiologist Fred Brown, who is advising states and nation states, including the incoming Biden Administration, on how to combat the pandemic

By |2021-01-01T17:39:43-05:00January 1st, 2021|Coronavirus, mitechtv, Science|

Epidemiologist Fred Brown Shares Booklet for Government Officials On How To Disperse Vaccines

ANN ARBOR - Fred Brown, who is working with states and nation states as a COVID-19 consultant, just completed a booklet he's sharing with government officials on how to disperse the virus vaccines now approved for public use. You also can view Fred's slide decks that illustrate his research and suggested remediations. If you want

By |2020-12-12T15:39:06-05:00December 12th, 2020|Coronavirus, mitechtv, Science|

Millendo Therapeutics Names Hoover Chief Commercial Officer

ANN ARBOR—Endocrine drug developer Millendo Therapeutics Inc. has promoted Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo in 2016 and has served as the company’s senior vice president of commercial strategy. “Tom has been instrumental in Millendo’s growth to date, and his promotion reflects his expanded responsibilities as well

By |2020-01-11T17:47:03-05:00January 11th, 2020|Life Sciences, Science|